Skip to main content

Monsanto Ordered To Take Deposition Of Man Dying From Cancer

Monsanto Ordered To Take Deposition Of Man Dying From Cancer

Monsanto Ordered To Take Deposition Of Man Dying From Cancer

Introduction

U.S. District Judge Vince Chhabria of the Northern District of California, presiding over all Roundup lawsuits, issued a pretrial order on Wednesday, February 6, indicating that Monsanto must take the deposition of a man dying of non-Hodgkin’s lymphoma (NHL) within 28 days of the order. The federal judge also granted the man's request for an early trial considering his deteriorating health condition.

According to the lawsuit filed by the plaintiff in 2015, he was diagnosed with non-Hodgkin's lymphoma as a result of exposure to Roundup herbicide. In October 2018, his oncologist revealed that his cancer was spreading rapidly and he had less than six months to live. In November 2018, the plaintiff requested that his case must be given preference over other bellwether trials scheduled to begin that month, or remand it back to the Southern District of California, as he may not live enough to witness the outcome of the first bellwether trial. Judge Chhabria stated in the order that man's claim would be included in the second group of bellwether trials, and the pretrial schedule for those claims would be finalized after the conclusion of the first bellwether.

Monsanto faces a steady flow of Roundup lawsuits alleging that the herbicide's glyphosate ingredient causes cancer to humans. A California couple, both suffering from NHL, was granted an expedited trial, which is set to begin in March 2019. Additional trials are scheduled against Monsanto in Missouri also, including a multi-plaintiff trial involving claims filed by 15 individuals, which will go before the jury in October this year. More than 600 Roundup lawsuits are pending in the federal court system where Judge Vince Chhabria overlooks the consolidated lawsuits in the multidistrict litigation (MDL No. 2741; In re: Roundup Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!